Transcription factor co-repressors in cancer biology: roles and targeting

Department of Pharmacology and Therapeutics, Roswell Park Cancer Institute, Buffalo, NY, USA.
International Journal of Cancer (Impact Factor: 5.01). 01/2010; 126(11):2511-9. DOI: 10.1002/ijc.25181
Source: PubMed

ABSTRACT Normal transcription displays a high degree of flexibility over the choice, timing and magnitude of mRNA expression levels that tend to oscillate and cycle. These processes allow for combinatorial actions, feedback control and fine-tuning. A central role has emerged for the transcriptional co-repressor proteins such as NCOR1, NCOR2/SMRT, CoREST and CTBPs, to control the actions of many transcriptional factors, in large part, by recruitment and activation of a range of chromatin remodeling enzymes. Thus, co-repressors and chromatin remodeling factors are recruited to transcription factors at specific promoter/enhancer regions and execute changes in the chromatin structure. The specificity of this recruitment is controlled in a spatial-temporal manner. By playing a central role in transcriptional control, as they move and target transcription factors, co-repressors act as a key driver in the epigenetic economy of the nucleus. Co-repressor functions are selectively distorted in malignancy, by both loss and gain of function and contribute to the generation of transcriptional rigidity. Features of transcriptional rigidity apparent in cancer cells include the distorted signaling of nuclear receptors and the WNTs/beta-catenin axis. Understanding and predicting the consequences of altered co-repressor expression patterns in cancer cells has diagnostic and prognostic significance, and also have the capacity to be targeted through selective epigenetic therapies.


Available from: Moray J Campbell, May 30, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The eukaryotic genomic regulatory elements that control transcription are considered. The review describes the functional anatomy of tissue-specific and housekeeping gene promoters, current methods to predict and to identify the enhancers, and the role insulators play in enhancer–promoter communication and maintenance of the epigenetic status of genome domains. The relationship between the topology of interphase chromatin and the regulation of transcription is outlined. Particular attention is paid to recent data obtained via high-throughput sequencing of primary transcripts and genome-wide analysis of histone modifications
    Molecular Biology 03/2015; 49(2):185-194. DOI:10.1134/S0026893315020119 · 0.74 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Inferring gene regulatory relationships from observational data is challenging. Manipulation and intervention is often required to unravel causal relationships unambiguously. However, gene copy number changes, as they frequently occur in cancer cells, might be considered natural manipulation experiments on gene expression. An increasing number of data sets on matched array comparative genomic hybridisation and transcriptomics experiments from a variety of cancer pathologies are becoming publicly available. Here we explore the potential of a meta-analysis of thirty such data sets. The aim of our analysis was to assess the potential of in silico inference of trans-acting gene regulatory relationships from this type of data. We found sufficient correlation signal in the data to infer gene regulatory relationships, with interesting similarities between data sets. A number of genes had highly correlated copy number and expression changes in many of the data sets and we present predicted potential trans-acted regulatory relationships for each of these genes. The study also investigates to what extent heterogeneity between cell types and between pathologies determines the number of statistically significant predictions available from a meta-analysis of experiments.
    PLoS ONE 08/2014; 9(8):e105522. DOI:10.1371/journal.pone.0105522 · 3.53 Impact Factor
  • Source
    Dataset: ijc29012